Ann: Endocoal Strategy Update , page-7

Correct gibba. The stock has now lost 37% of its value since the report.
Progress to date has been disappointing and the market agrees.
This was hailed as the next Felix around IPO time. Reality is it has a long way to go to be even worth 5% of what Felix sold for.